OH2 and BS006 injection for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a combination of two injections, OH2 and BS006, for people with advanced solid tumors that have not responded to standard treatments. The injections are given directly into the tumor, aiming to shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced solid tumors like melanoma, head and neck cancer, or liver cancer that standard treatments haven't helped.
- You are between 18 and 75 years old and able to care for yourself (ECOG score 0-1).
- You have at least one tumor that can be injected and is large enough to measure (at least 1 cm in size).
- It has been at least 4 weeks since your last cancer treatment and you have recovered from major side effects.
- Your blood counts, kidney, liver, and clotting functions are within acceptable levels.
- You do not have serious heart problems, uncontrolled infections, or active autoimmune diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests OH2 given as an injection directly into certain tumors (intratumoral injection) in people with advanced melanoma or several other solid cancers that are hard to remove. It aims to see whether the treatment is safe and if it can help control cancer by reaching the tumor more directly.
This early-stage study tests a virus therapy designed to attack solid tumors that cannot be removed by surgery or have returned/spread. It may help shrink tumors and control cancer in people whose standard treatments are no longer working.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This trial tests an investigational cell therapy called HS-IT201 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if this treatment can help shrink tumors or slow their growth.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This trial tests a new drug called HB0052 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective for various cancer types.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.